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The locus coeruleus (LC), which contains the largest group of noradrenergic neurons
in the central nervous system innervating the telencephalon, is an early and constantly
vulnerable region to neurofibrillary tangle (NFT) pathology in aging and Alzheimer’s
disease (AD). The present study using whole genome bisulfite sequencing and Infinium
Human Methylation 450 BeadChip was designed to learn about DNA methylation
profiles in LC with age and NFT pathology. This method identified decreased DNA
methylation of Katanin-Interacting Protein gene (KIAA0566) linked to age and presence of
NFT pathology. KIAA0566 mRNA expression demonstrated with RT-qPCR significantly
decreased in cases with NFT pathology. Importantly, KIAA0566 immunoreactivity was
significantly decreased only in LC neurons with NFTs, but not in neurons without tau
pathology when compared with neurons of middle-aged individuals. These changes
were accompanied by a similar pattern of selective p80-katanin reduced protein
expression in neurons with NFTs. In contrast, p60-katanin subunit expression levels in
the neuropil were similar in MA cases and cases with NFT pathology. Since katanin is
a major microtubule-severing protein and KIAA0566 binds and interacts with katanin,
de-regulation of the katanin-signaling pathway may have implications in the regulation
of microtubule homeostasis in LC neurons with NFTs, thereby potentially interfering with
maintenance of the cytoskeleton and transport.
Keywords: Alzheimer’s disease, locus coeruleus, neurofibrillary tangles, methylation, katanin, KIAA0556,
microtubules
INTRODUCTION
Studies of Alzheimer’s disease (AD) are mainly focused on the entorhinal cortex, hippocampus,
and neocortex because of the massive accumulation with disease progression of β-amyloid
deposits (diffuse and senile plaques) and hyper-phosphorylated tau-containing neurofibrillary
tangles (NFTs), neuropil threads, and dystrophic neurites in these regions. Recently, the study
of the brainstem in AD has captivated attention as (a) several nuclei of the brain stem such as
the raphe nuclei and locus ceruleus (LC) are early and constantly affected in AD by abnormal
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neuronal deposition and formation of NFTs; (b) these nuclei
are the main source of serotoninergic and noradrenergic
innervations of the telencephalon including cerebral cortex; and
(c) several functions dependent on the integrity of these nuclei
such as arousal, attention, sleep-awake cycles, emotional states
(control of panic, anxiety, and depression), autonomic function,
memory and learning, stress responses, and motor coordination,
among others, are altered in AD (Rüb et al., 2001; Aston-Jones
and Cohen, 2005; Grinberg et al., 2009; Simic et al., 2009;
Šimic´ et al., 2016; Attems et al., 2012; Szabadi, 2013). Whole-
transcriptome arrays in LC reveal up-regulation of genes coding
for proteins associated with heat shock protein binding and genes
associated with ATP metabolism, and down-regulation of genes
coding for DNA-binding proteins and members of the small
nucleolar RNA family in LC neurons at early stages of NFT
pathology (Andrés-Benito et al., 2017). MicroRNA expression is
altered in the LC at early stages of NFT pathology (Llorens et al.,
2017). These observations indicate alterations in the mechanisms
leading to gene transcription and protein translation in LC at
early stages of AD-related pathology.
DNA methylation and other epigenetic mechanisms which
are modulators of gene transcription are altered in several
neurodegenerative diseases including AD (Jakovcevski and
Akbarian, 2012; Lu et al., 2013; Sanchez-Mut et al., 2014;
Lardenoije et al., 2015; Blanch et al., 2016; Watson et al., 2016;
Wen et al., 2016; Nicolia et al., 2017; Roubroeks et al., 2017; Smith
and Lunnon, 2017). Epigenetic deregulation of brainstem nuclei
has been postulated as one of the primary mechanisms in the
pathogenesis of AD (Iatrou et al., 2017). The present work focuses
on the study of DNA methylation in dissected LC in cases with
NFT pathology compared with middle-aged individuals. Since
one of the differentially methylated genes is KIAA0556, which
encodes katanin-Interacting Protein, the study is then redirected
to the analysis of expression of KIAA0556 mRNA and protein,
and the proteins katanin subunit 60 and katanin subunit 80
(p60-katanin and p80-katanin, respectively) to assess possible
alterations in katanin pathway signaling linked to NFT pathology
in LC.
MATERIALS AND METHODS
Human Brain Samples
Human brain samples were obtained from the Institute of
Neuropathology Brain Bank (HUB-ICO-IDIBELL Biobank)
following the guidelines of the Spanish legislation on this matter
(Real Decreto 1716/2011) and approval by the local ethics
committee of the Bellvitge University Hospital-IDIBELL. The
post-mortem interval between death and tissue processing was
between 2 h 45min and 15 h. This interval permits the study
of RNA and protein expression as assessed elsewhere (Ferrer
et al., 2008). One hemisphere was immediately cut in coronal
sections, 1 cm thick, and selected areas of the encephalon were
rapidly dissected, frozen on metal plates over dry ice, placed
in individual air-tight plastic bags, and stored at −80◦C until
use. The other hemisphere was fixed by immersion in 4%
buffered formalin for 3 weeks. The brain stem was cut on
tangential sections 2mm thick which were alternately frozen
at −80◦C or fixed in buffered formalin for 3 weeks. The
neuropathological study for diagnosis was carried out with
selected 4 µm-thick de-waxed paraffin sections of representative
brain regions processed for immunohistochemistry as detailed
elsewhere (Ferrer, 2014). Neuropathological diagnosis was based
on the Braak and Braak stages of neurofibrillary tangle (NFT)
pathology (Braak and Braak, 1991; Braak et al., 2006) and Thal
phases of β-amyloid deposits (Thal et al., 2002). Cases with
combined pathologies, excepting small blood vessel disease, and
cases with metabolic syndrome, hypoxia, seizures, and long
agonic state, were excluded. Since early stages of sporadic AD
may show only NFT pathology without β-amyloid deposition
Ferrer, 2012; Braak and Del Tredici, 2015), and these changes are
similar to those seen in Primary age-related tauopathy (PART)
(Crary et al., 2014; Duyckaerts et al., 2015), no attempt was made
here to distinguish between early AD and PART, thus considering
as pathological cases those containing NFTs grade according to
Braak categorization stages. Cases were divided in two series.
One series was used for DNA methylation studies; the LC of
both sides was dissected from frozen samples. These cases were
as follows: middle-aged cases (MA): n = 3, mean age: 50 ± 1
years; NFT pathology stages I-II, n = 4, age: 68 ± 6.3; NFT
pathology stages III-IV, n = 7, age 85.1 ± 7.0; NFT pathology
stages V-VI, n = 6, age: 76.3 ± 12.5 years. The second series was
used for RT-qPCR after dissection of LC from frozen sections,
and immunofluorescence and confocal microscopy carried out
on serial sections containing the LC fixed in buffered formalin.
These cases were the following: MA, n = 9, age: 51.0 ± 6.1; NFT
pathology stages I-II, n = 9, age: 64.6 ± 5.7; and NFT pathology
stages III-IV, n = 13, age: 78.1 ± 8.0. Cases in the second series
were not affected by β-amyloid deposits, as phases 1 and 2 of Thal
do not affect the LC.
Cases are summarized in Table 1. No differences in gender
distribution were observed in these series. See comments below
about age differences among groups.
Regarding clinical phenotype, MA cases and cases with NFT
pathology stages I-III were normal; some cases at stage IV (cases
20, 40 and 41) had suffered from mild cognitive impairment, and
cases at stages V-VI were categorized as dementia of AD type.
DNA Extraction and Illumina Infinium
Human MethylationEPIC BeadChip
Cases used for DNA methylation are detailed in Table 1.
Total DNA was isolated from microdissected LC with DNeasy
Blood and Tissue Kit (Qiagen, Madrid, Spain) according to
the manufacturer’s instructions. All DNA samples were assessed
for integrity, quantity, and purity with electrophoresis in a
1.3% agarose gel, with picogreen quantification and nanodrop
measurements. Bisulfite conversion of 500 ng of genomic DNA
was performed using EZ DNA methylation kit (Zymo Research,
Irvine, CA, USA) following the manufacturer’s instructions.
200 ng of bisulfite-converted DNA was used for hybridization
on the Illumina Infinium Human MethylationEPIC BeadChip
(Illumina Inc., San Diego, CA, USA). Briefly, samples were
whole genome-amplified, followed by an enzymatic end-
point fragmentation, precipitation, and re-suspension. The re-
suspended samples were hybridized onto the bead-chip for
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TABLE 1 | Summary of cases analyzed in the present series.
Case Age Sex Thal Braak PMD RIN RTqPCR Methylation
1 64 M 1 I 04 h 35min 6.2 X -
2 73 M 0 I 07 h 05min 6.6 X -
3 56 W 1 I 08 h 00min 6.3 X -
4 67 M 0 I 14 h 40min 5.9 X -
5 70 M 1 I 02 h 00min 7.6 X -
6 61 M 0 I 04 h 30min 6.9 X -
7 66 M 0 I 12 h 10min 5.8 X -
8 68 W 1 II 04 h 30min 6.7 X -
9 57 M 0 II 04 h 30min 6.7 X -
10 90 W 1 III 04 h 00min 7.1 X -
11 78 W A III 06 h 00min 6.8 X -
12 69 M 0 III 13 h 10min 7.2 X -
13 64 M 2 III 06 h 00min 7.0 X -
14 90 W 1 III 04 h 00min 7.1 X -
15 73 M 0 III 04 h 15min 8.0 X -
16 75 M 1 III 03 h 25min 6.2 X -
17 76 M 1 III 06 h 00min 5.8 X -
18 76 M 1 III 06 h 00min 5.8 X -
19 78 W 2 III 06 h 00min 6.8 X -
20 74 M 2 IV 04 h 45min 6.2 X -
21 84 M 2 IV 10 h 50min 7.0 X -
22 89 M 2 IV 03 h 20min 7.0 X -
23 44 M 0 0 06 h 40min 6.7 X -
24 52 M 0 0 03 h 00min 6.8 X -
25 52 M 0 0 04 h 40min 7.6 X -
26 52 W 0 0 05 h 45min 6.4 X -
27 41 M 0 0 11 h 35min 5.9 X -
28 60 W 0 0 11 h 30min 5.8 X -
29 59 M 0 0 08 h 30min 6.6 X -
30 51 W 0 0 04 h 00min 5.9 X -
31 48 W 0 0 14 h 30min 6.1 X -
32 64 M 0 I 08 h 00min - - X
33 68 M 0 I 10 h 55min - - X
34 77 M 1 I 06 h 55min - - X
35 63 M 0 I 02 h 45min - - X
36 79 W 2 III 03 h 40min - - X
37 82 W 2 III 03 h 05min - - X
38 81 M 1 III 05 h 50min - - X
39 90 W 1 IV 09 h 55min - - X
40 81 W 3 IV 05 h 00min - - X
41 99 W 2 IV 05 h 00min - - X
42 84 M 2 IV 12 h 15min - - X
43 74 W 2 V 05 h 30min - - X
44 95 M 3 V 03 h 00min - - X
45 81 W 3 V 05 h 15min - - X
46 75 M 3 V 11 h 30min - - X
47 77 M 3 V 16 h 00min - - X
48 56 W 4 VI 07 h 00min - - X
49 59 M 0 0 06 h 25min - - X
50 53 M 0 0 07 h 25min - - X
51 46 M 0 0 15 h 00min - - X
Age in years; M, man; W, woman; Thal phases of β-amyloid deposition; Braak stages of neurofibrillary tangle pathology; PMD, post-mortem delay; RIN, RNA integrity number; RTqPCR,
cases used for RT-qPCR and immunofluorescence; Methylation, cases assessed for DNA methylation. Cases 23-31 and 49–51 were considered middle-aged (MA) individuals with no
NFT and plaque pathology.
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16 h at 48◦C and then washed. A single nucleotide extension
with labeled dideoxy-nucleotides was performed, and repeated
rounds of staining were applied with a combination of
fluorescently labeled antibodies differentiating between biotin
and DNP. Fluorescent signal from the microarray was measured
with a HiScan scanner (Illumina Inc.,) using iScan Control
Software (V 3.3.29). A three-step-based normalization procedure
was performed using a package available for Bioconductor
(Gentleman et al., 2004), under the R statistical environment,
consisting of color bias adjustment, background level adjustment,
and quantile normalization across arrays (Du et al., 2008).
Methylation level (β-value) for each of the 866,836 CpG sites
was calculated as the ratio of methylated signal divided by
the sum of methylated and unmethylated signals plus 100. All
beta values with an associated p ≥ 0.01 were removed from
the analysis.
Gene Expression Validation
Samples used for RT-qPCR analysis are detailed in Table 1.
RNA from frozen dissected LC was extracted following
the instructions of the supplier (RNeasy Mini Kit; Qiagen
GmbH, Hilden, GE). RNA integrity number (RIN) and 28/18 S
ratios were determined with the Agilent Bioanalyzer (Agilent
Technologies, Santa Clara, CA, USA) to assess RNA quality;
RNA concentration was evaluated using a NanoDropTM
Spectrophotometer (Thermo Fisher Scientific, Carlsbad, CA,
USA). RIN (RNA integrity number) values varied from 5.8
to 7.6 with no significant differences among groups. Retro-
transcription reaction of RNA samples was carried out with the
high-capacity cDNA archive kit (Applied Biosystems, Foster City,
CA, USA) following the guidelines provided by the manufacturer
and using Gene Amp 9700 PCR System thermocycler (Applied
Biosystems). One sample of RNA was processed in parallel
in the absence of reverse transcriptase to rule out DNA
contamination.
Quantitative real-time polymerase chain reaction (RT-qPCR)
assays were conducted in duplicate on cDNA samples obtained
from the retro-transcription reaction diluted 1:10 in 384-well
optical plates (Kisker Biotech, Steinfurt, GE) utilizing the
ABI Prism 7900 HT Sequence Detection System (Applied
Biosystems). TaqMan probes (Thermo Fisher Scientific) were
Hs00390731_m1 (KIAA0556 probe) and Hs01125994_m1
(UTRN probe). The mean value of four house-keeping genes,
alanyl-transfer RNA synthase (AARS) (Hs00609836_m1),
glucuronidase Beta (GUS-β) (Hs00939627_m1), hypoxanthine-
guanine phosphoribosyltransferase (HPRT1) (Hs02800695_m1),
and X-prolyl amino-peptidase (aminopeptidase P) 1 (XPNPEP1)
(Hs00958026_m1), were used as internal controls for
normalization of LC samples (Barrachina et al., 2006;
Durrenberger et al., 2012). DDCT values were obtained from the
DCT of each sample minus the mean DCT of the population
of control samples (calibrator samples). The fold change was
determined using the equation 2DDCT. Mean fold change values
in each group were analyzed with the Students t-test using the
Statgraphics Statistical Analysis and Data Visualization Software
version 5.1.
Double-Labeling Immunofluorescence and
Confocal Microscopy
Cases used for immunofluorescence are named 10–31 in Table 1
(stages I-II were not examined). Three de-waxed sections, 4µm
thick, per selected cases were stained with a saturated solution of
Sudan black B (Merck, Barcelona, Spain) for 15min to block the
auto-fluorescence of lipofuscin granules present in cell bodies,
and then rinsed in 70% ethanol and washed in distilled water.
The sections were incubated at 4◦C overnight with combinations
of primary antibodies: anti-KIAA0556 diluted 1:250 (NBP1-
91006, NovusBiologicals, USA), anti-p60 katanin subunit diluted
1:250 (MAB7100, R&D systems, USA), anti-p80 katanin subunit
diluted 1:150 (ab224171, Abcam, UK), and antibody AT8
diluted 1:50 (MN1020, ThermoFisher, USA). After washing,
the sections were incubated with Alexa488 or Alexa546 (1:400;
Molecular Probes, Eugene, OR, USA) fluorescence secondary
antibodies against the corresponding host species. Nuclei were
stained with DRAQ5TM (1:2,000; Biostatus, Shepshed, UK).
After washing, the sections were mounted in Immuno-Fluore
mounting medium (ICN Biomedicals, Santa Clara, CA, USA),
sealed, and dried overnight. Sections were examined with a
Leica TCS-SL confocal microscope (Leica, Barcelona, Spain),
and the images were acquired with Leica confocal software.
Densitometry of the immunoreaction signal in LC positive
cells for KIAA0556 and p80 was performed using Photoshop
software in three different sections per case. Comparisons
were made between control and diseased cases, and between
neurons with and without NFT pathology in pathological cases.
Densitometry of p60 immunostaining was performed in the
whole neuropil of the LC due to punctate characteristics of
p60 immunostaining.
Statistical Analysis
The effect of age and NFT pathology were determinant in DNA
methylation and RT-qPCR expression. These aspects were further
interpreted on the basis of immunohistochemical studies and
quantification of data.
The normality of the data was assessed with the Shapiro-
Wilk test or Kolmogorov–Smirnov test when required. DNA
methylation data and RT-qPCR data were compared with one-
way analysis of variance (ANOVA) followed by Tukey post-
test. Statistical analysis and graphic design were performed with
GraphPad Prism version 5.01 (La Jolla, CA, USA). Outliers were
detected using the GraphPad software QuickCalcs (p < 0.05).
Significance levels were set at ∗p < 0.05 and ∗∗p < 0.01.
Statistical analysis of densitometric protein levels between
groups, as revealed by immunofluorescence, was performed
using t-student’s test or one-way analysis of variance (ANOVA)
followed by Tukey post-test when required using the SPSS
software (IBM Corp. Released 2013, IBM SPSS Statistics for
Windows, Version 21.0. Armonk, NY: IBM Corp.). Outliers were
detected using the GraphPad software QuickCalcs (p< 0.05). All
data were expressed as mean values± SEM. Differences between
middle-aged andNFT(+) were considered statistically significant
at ∗p < 0.05, ∗∗p < 0.01, ∗∗∗p < 0.001, and set at $ p < 0.05 and
$$ p< 0.01 when comparing NFT(–) and NFT(+) neurons.
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FIGURE 1 | (A) Hierarchical clustering heat map of methylation (5mC) (left) and hydroxmethylation (5hmC) (right) array showing differential methylation profile in LC in
cases with neurofibrillary tangle (NFT) pathology and middle-aged individuals (MA). Differences between groups are here considered statistically significant at an
adjusted p < 0.05 in methylation study and at an unadjusted p < 0.05 in hydroxymethylation study. (B) Box plot of CpG methylation differences between MA and
cases at different stages of NFT pathology (I-II, III-IV, and V-VI) in UTRN (left) and KIAA0556 (right) genes. Significant differences in KIAA0556 DNA 5mC are seen
between MA and all stages of NFT pathology. Abbreviations: 5mC: methylation; 5hmC: hydroxymethylation, UTRN: utrophin; KIAA0556: Katanin-interacting protein.
Samples color code: gray: MA cases; black: cases with NFT pathology.
FIGURE 2 | Gene expression levels of UTRN and KIAA0556 genes in LC in
MA and cases with NFT pathology at stages I-II and III-IV. *p < 0.05 when
comparing MA with NFT III-IV.
RESULTS
Differential Methylation Regions
Illumnia Infinium Human MethylationEPIC BeadChip Kit was
used, covering over 850,000 methylation sites quantitatively
across the genome at single-nucleotide resolution, which permits
discrimination between 5mC and 5hmC. DNA methylation
profiles obtained from this platform showed a few differential
methylation regions (DMRs) when comparing MA individuals
with cases showing various stages of NFT pathology. After
the Lumi software analysis, coding DMRs showing significant
differences at an adjusted p < 0.05 were sorted and ranked
according to their CpG mean differences and significance
(Supplementary Table 1). In contrast, 5hmC data obtained when
comparing NFT stages with MA cases did not reveal significant
differences following the same adjusted p-value established for
5mC (Figure 1A). For this reason no further attempt was
made to analyze gene expression of suspected hydroximethylated
genes. Enrichment analysis against the “Go Ontology” database
did not identify significant clusters for coding DMRs in
ases with NFT pathology. Two significant DMRs, UTRN
and KIAA0556 genes, coding for utrophin and katanin-
Interacting Protein, respectively, were differentially hypo-
methylated in cases with NFT pathology when compared with
MA individuals. Differences were more marked for KIAA0556
when comparing MA with early stages of NFT pathology
(Figure 1B).
Gene Expression Validation
RT-qPCR was performed to evaluate UTRN and KIAA0556
mRNA expression.UTRNmRNA expression did not significantly
differ in MA and cases with NFT pathology. In contrast,
KIAA0556 mRNA expression was significantly reduced at stages
III-IV of NFT pathology when compared with MA individuals
(p= 0.002; Figure 2).
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FIGURE 3 | Double-labeling immunofluorescence and confocal microscopy to KIAA0556 (green) and hyper-phosphorylated tau (clone AT8: red) in MA and in one
case with NFT pathology stage IV. Note decreased KIAA0556 restricted to neurons containing NFT (arrowhead: only red; arrows: only green). Lower row: higher
magnification of the upper right corner showing decreased KIAA0556 immunoreactivity in one neuron containing NFT. Paraffin sections; nuclei stained with DRAQ5TM
(blue); bar in the two upper rows = 50µm; bar in the lower row = 25µm.
Protein Expression of KIAA0556, and
Katanin p80 and p60 Subunits in LC
Double-labeling immunofluorescence and confocal microscopy
to selected proteins and hyperphosphorylated tau (antibody
AT8) were used to a: identify localization of KIAA0556,
and katanin p80 and p60 subunits in LC; b: assess
modified expression levels of these proteins in cases
with NFT pathology; and c: analyze the relationship, if
any, between KIAA0556, and katanin p80 and p60, in
relation to tau deposition in neurons and neuropil of the
LC.
KIAA0556 immunoreactivity was observed in the cytoplasm
of neurons in MA and in cases with NFT pathology;
the immunoreactivity was similar in neurons from MA
cases and in neurons without NFTs in cases with NFT
pathology. But KIAA0556 immunoreactivity was markedly
reduced in neurons with NFTs, as revealed by double-
labeling immunofluorescence and confocal microscopy
(Figure 3). Quantitative studies showed no differences in
the amount of protein in neurons of the LC in MA individuals
and in non-containing NFT neurons in cases with NFT
pathology stages III-IV. However, significant reduction
of KIAA0556 immunoreactivity was verified in neurons
containing hyper-phosphorylated tau deposits when compared
with neurons not bearing NFTs in the same tissue section
(p= 0.002) (Figure 6A).
To further learn about KIAA0556-associated proteins,
double-labeling immunofluorescence to p60- and p80-katanin
subunits was assessed. p60-katanin immunoreactivity was
localized as punctuate, synaptic-like deposits in the neuropil
in MA and cases at stages III-IV of NFT pathology, which was
consistent with the localization of this protein in distal neuronal
processes. Double-staining of p60-katanin and AT8 showed
no apparent decrease in p60-katanin immunoreactivity in the
neuropil of the LC in cases with NFT pathology when compared
with MA (Figure 4). Densitometry revealed no significant
differences between the two groups (p= 0.62; Figure 6B).
Finally, p80-katanin protein expression was localized in
the cytoplasm of LC neurons. p80-katanin immunoreactivity
was selectively reduced in neurons of the LC containing
hyperphosphorylated tau deposits (Figure 5). Densitometric
analysis further demonstrated no differences between MA
neurons and neurons without tau deposits in cases with
NFT pathology, but significant reduction of p80-katanin
immunoreactivity in neurons with NFTs when compared with
neurons without NFTs in the same tissue section (p = 0.000;
Figure 6C).
DISCUSSION
DNA methylation at 5-methylcytosine (5mC) is an epigenetic
mechanism associated primarily with transcriptional repression,
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FIGURE 4 | Double-labeling immunofluorescence and confocal microscopy to p60-katanin (green) and hyper-phosphorylated tau (clone AT8: red) in MA and in one
case with NFT pathology stage IV. Lower row: higher magnification of the upper right corner showing preserved p60-katanin immunoreactivity in the neuropil in NFT
case when compared with MA. Paraffin sections; nuclei stained with DRAQ5TM (blue); bar in the two upper rows = 50µm; bar in the lower row = 25µm.
whereas methylation at 5-hydroxymethylcytosine (5hmC) has
opposite effects. Here we used hybridization on the Illumina
Infinium Human MethylationEPIC BeadChip to identify
differences in DNA methylation of dissected LC of cases with
NFT pathology compared with MA individuals without NFTs.
The age of the two groups was different, with cases with NFT
pathology being older than MA individuals. This is not a rare
situation as 85% of human beings aged 65 years and older
show NFT pathology defined, minimally, as stages I-II of Braak
in the entorhinal cortex (EC). Most of them, if not all, have
hyper-phosphorylated tau deposits in the LC (Braak et al., 2011;
Ferrer, 2012). Indeed, tau pathology in certain nuclei of the
brain stem, including LC, precedes tau pathology in the EC (Rüb
et al., 2001; Grinberg et al., 2009; Simic et al., 2009; Attems et al.,
2012). For this reason, the MA group was selected on the basis
of the absence of tau pathology in LC. It can be argued that
the present design is biased by age differences between the two
main groups. This objection may be true in other situations, but
present observations geared to learning about the association of
NFT pathology and abnormal gene expression in neurons of the
LC proved it not to be here.
Using restrictive conditions, two DNA hypo-methylated genes
were selected for further study; UTRN and KIAA0556 genes,
coding for utrophin and katanin-Interacting Protein, were
differentially hypo-methylated in cases with NFT pathology
when compared with MA individuals. RT-qPCR showed no
differences in UTRN mRNA expression between the two groups.
However,KIAA0556mRNA expression was significantly reduced
in cases with NFT pathology when compared with MA. Lack of
correlation between degree of DNA methylation of CpG islands
as revealed by the bisulphate methods and gene transcription is
not a rare phenomenon in diseases of the nervous system (Nicolia
et al., 2017).
Altered KIAA0556 mRNA expression in neurons with NFT
may have implications in microtubule pathology in neurons
bearing hyper-phosphorylated tau in LC. Microtubules are
hollow polymers of α- and β-tubulin subunits with one end, the
plus-end, favored by the addition and subtraction of subunits,
while the minus-end has limited turnover capacity; β-tubulins
predominate at the plus-end and α-tubulins at the minus-end
(Baas and Lin, 2011; Baas, 2013; Kapitein and Hoogenaad,
2015; Baas et al., 2016). This structure permits high plasticity;
long microtubules shape the morphology and stability of
dendrites and axons, and serve as a means to transport distinct
molecules over long distances; short microtubules permit the
growth of microtubules and the transport of tubulins (Baas
et al., 2016). Stability of microtubules is in part related to
tubulin polyamination catalyzed by transglutaminases (Song
et al., 2013; Song and Brady, 2015). Several proteins bind to
microtubules and modulate stabilization of microtubules; tau
and other microtubule-associated proteins (MAPs) have repeats
of microtubule-binding domains and prevent de-polymerization
of microtubules (Mandelkow and Mandelkow, 1995; Kadavath
et al., 2015). Tau hyper-phosphorylation, as occurs in NFTs,
Frontiers in Cellular Neuroscience | www.frontiersin.org 7 May 2018 | Volume 12 | Article 131
Andrés-Benito et al. Regulation of KIAA0566 in LC in NFT
FIGURE 5 | Double-labeling immunofluorescence and confocal microscopy to p80-katanin (green) and hyper-phosphorylated tau (clone AT8: red) in MA and in one
case with NFT pathology stage IV. Note decreased p80-katanin restricted to neurons containing NFT (arrowhead: only red; arrows: only green). Lower row: higher
magnification of the upper right corner showing decreased p80-katanin immunoreactivity in one neuron containing NFT. Paraffin sections; nuclei stained with
DRAQ5TM (blue); bar in the two upper rows = 50µm; bar in the lower row = 25µm.
FIGURE 6 | Densitometric study showing no differences in p60 protein expression between LC neurons in MA cases and tau non-bearing neurons in cases with NFT
pathology (B), but significant KIAA0556 (A), and p80-katanin (p80) (C) reduction in NFT-containing neurons when compared with non-tau containing neurons in the
same sections. *p < 0.05 when comparing MA with NFT, and $$p < 0.01 and $$$p < 0.001 when comparing NFT(−) and NFT(+) neurons in cases with NFT
pathology.
results in tau dissociation from microtubules and aberrant
formation of paired helical filaments (Alonso et al., 1999; Buée
and Delacourte, 2001; Avila, 2006; Goedert et al., 2006;Wang and
Liu, 2008; Duan et al., 2012; Matamoros and Bass, 2016).
Microtubule-severing proteins are proteins which form
hexamers on the surface of microtubules and break the
microtubules into fragments that can be transported to distinct
places of the cytoplasm, axon, and dendrites to produce
new microtubules, as only short microtubules are able to
be transported (Wang and Brown, 2002; Baas et al., 2006;
Roll-Mecak and McNally, 2010). Katanin is one of the most
abundant microtubule-severing proteins in brain and plays
an important role in axonal growth and dendrite branching
during development due to its participation in the generation
of microtubules (Ahmad et al., 1999; Yu et al., 2005, 2008;
Roll-Mecak and Vale, 2006). Increased activity of microtubule-
severing proteins also has noxious effects as it is accompanied by
degradation of the neuronal cytoskeleton (Yu et al., 2005; Sudo
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and Baas, 2011). p60-katanin is localized in neuronal processes
and severs microtubules whereas p80-katanin is localized in the
cytoplasm at the centrosomes (McNally et al., 2000; Yu et al.,
2005). Tau seems to protect microtubules in the axon from
severing by katanin (Qiang et al., 2006). Following on from
this posit, it has been suggested that hyper-phosphorylated tau
loses its function as protector and randomly enables microtubule
severing by katanin (Qiang et al., 2006; Sudo and Baas, 2011).
KIAA0556 co-localizes with α-tubulin, and binds to p60-
and p80-katanin subunits (Sanders et al., 2015). Moreover,
KIAA0556 seems to negatively regulate katanin severing (Sanders
et al., 2015). Mutations of KIAA0556 gene are causative of
Joubert syndrome, which is manifested by several malformations
including brain (Sanders et al., 2015; Roosing et al., 2016).
Considering all these data, the expression of proteins
KIAA0556, and p60- and p80-katanin was considered a next
step in the study of possible alterations of this pathway
in the LC in neurons with NFT pathology. Double-labeling
immunofluorescence with antibodies to these proteins, and to
phosphorylated tau, disclosed no differences in the expression of
KIAA0556 and p80-katanin in LC neurons of MA cases and in
neurons without hyper-phosphorylated tau deposits in cases with
NFT pathology. Moreover, no significant differences were seen in
p60-katenin expression in the neuropil of cases with and without
NFT pathology. These findings support the idea that age, per se, is
not a determining factor in the altered expression of KIAA0556
and p80-katanin in LC neurons. Yet it is the presence of NFTs
which makes the difference; KIAA0556 and p80-katanin protein
are reduced only in neurons with NFTs.
Together, the present findings show association of decreased
KIAA0556 and p80-katanin subunits in LC neurons with NFTs,
and suggest that altered microtubule homeostasis in those
neurons is linked to deregulation of the katanin-signaling
pathway.
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